Latest pharma feed

Pharma Research & Development

Pharma Research & Development

Latest Research

Geliose Mobility, an IIT Delhi incubated startup, launches ‘HOPE’, an affordable electric scooter for last mile delivery and personal commute

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 202

Predicting T Cell Recognition: New Insights from Large-Scale Activation Data

A study accepted to ML4H 2025 explores whether sequence-based models trained on large-scale T-cell a...

GAP Nail™ Endo-Exo Medullary System

Decision: Advertising investigations: March 2026

Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines...

Kennedy expands ACIP function, membership criteria

Amending his previous two-year-renewal of the standard charter for the U.S. CDC’s Advisory Committee...

日本新薬とイクスフォレストセラピューティクス RNA構造を標的とした創薬研究に関する契約を締結

Virtual Twins: What They Are & Their Impact in Life Sciences

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2026

PRAC agrees on communication to healthcare professionals about cases of severe liver injury with epi...

eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast

On the Grow Everything podcast, CCO of eXoZymes, Damien Perriman, breaks down why cell-free biomanuf...

ANMAT concluyó el proceso para la baja definitiva de las firmas HLB PHARMA GROUP S.A. y LABORATORIOS RAMALLO S.A.

Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)

「デジタルトランスフォーメーション銘柄（DX銘柄）2026」選定のお知らせ

中外製薬株式会社 （本社：東京、代表取締役社長 CEO：奥田 修）は、このたび、経済産業省、東京証券取引所及び独立行政法人情報処理推進機構が選定する「デジタルトランスフォーメーション銘柄（DX銘柄）2...

Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026&rdquo

TOKYO, April 10, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it has b...

A Clínic-IDIBAPS study discovers that nanoparticles with DNA enhance the effect of immunotherapy against cancer

A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has s...

Differences in cells’ protein factories may help explain human diversity

[SHINSA]Considerations for clinical development of intravenous formulations containing the same active ingredient as oral products for patients who are temporarily unable to receive oral administration in epilepsy treatment （Early consideration） posted

Early Consideration is reference information and point of view at that time for promoting the practi...

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases

Analysis of NPC1 Genotypes: Findings From the US Arimoclomol Expanded Access Program for Niemann-Pick Disease Type C

Why do anglerfish have glowing lures? It might be sex

Shionogi Selected as a “DX Stock 2026”

The DX Stock program evaluates and selects companies that are transforming their business models and...

Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 20264/10/2026 Press release

ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for Januar...

CD22-targeted immunotherapy for B-cell acute lymphoblastic leukemia progressing following CD19-targeted immunotherapy

Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer

SLC25A1 upregulation promotes HNSCC cisplatin resistance via H3K27ac-mediated cellular senescence

Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma

Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study

The role of the molecular tumor board: learnings from the ROME trial

Deep learning-based pathomics signature predicts prognosis and treatment response in gastric cancer: a multicenter retrospective study

Idorsia Media Release

Idorsia Ltd is listed on the SIX Swiss Stock exchange, we provide an archive of our media releases o...

Idorsia News archive

Idorsia Ltd is listed on the SIX Swiss Stock exchange, we provide an archive of our media releases o...

Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders

Behind the Science magazine | GSK

Apr 10,2026 | Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026” | News | CHUGAI PHARMACEUTICAL CO., LTD.

Stroke Visionaries: Dr. Erika Weil

Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Viking Therapeutics to Participate at Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focu...

IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plan...

WHO releases US$800,000 from its Contingency Fund for Emergencies for Iran health response

10 April 2026, Cairo, Egypt – The World Health Organization (WHO) has released US$800,000 from its C...

Foundayo™ (orforglipron), la nueva pastilla GLP-1 de Lilly que se administra por vía oral para la pérdida de peso, ahora está disponible en Estados Unidos.

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Rick Byrd to Retire from BD

From Signal to Strategy: Using current, credible data for publication impact monitoring and continuous improvement planning

From Signal to Strategy: Using current, credible data for publication impact monitoring and continuous improvement planning

PPC Landing Page Template VHH Services V.2

University College of London Hospitals NHS Trust (UCLH)

Cambridge University Hospitals NHS Foundation Trust

Manchester University NHS Foundation Trust

Hôpital La Pitié Salpêtrière

University of Oklahoma

ISPOR 2026

Clinical investigations for medical devices

How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.

Delpharm to attend CDMO Live Europe 2026

Guidance: Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway

By streamlining decision-making, the MHRA–NICE aligned pathway will help patients access new medicin...

National assessment procedure for medicines

Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Viz.ai Earns Back-to-Back No. 1 Ranking in Black Book Survey of AI Clinical Decision Support Solutions

Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs

Interest is growing around strategies that target the body’s internal energy system itself. Instead...

Delpharm na targach CDMO Live Europe 2026

Delpharm presente al CDMO Live Europe 2026

Delpharm présent au CDMO Live Europe 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Med...

Simplificación de los mecanismos de inscripción para productos importados cosméticos, domisanitarios e higiénicos

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy

Canon launches Ultimion, Japan’s first domestically produced Photon-Counting CT

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

Targeted therapy in early-stage classical Hodgkin lymphoma

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de un lote del cosmético Agrado crema solar SPF 50

Jakość jako podstawowe zobowiązanie

Onbeschikbaarheid van Fibclot 1,5 g poeder en oplosmiddel voor injectie/infusie: aanbevelingen voor artsen-specialisten en ziekenhuisapothekers

Het geneesmiddel Fibclot 1,5 g is tijdelijk onbeschikbaarheid van 9 oktober 2025 tot 31 januari 2027...

Farmak Ranked Among Ukraine’s Top 10 Employers

A simple model makes it possible to predict which patients experiencing a first psychotic episode will recover during the first year

A multicentre team, led by Sergi Mas, lecturer in the Pharmacology Unit of the Department of Clinica...

抗CD20モノクローナル抗体「リツキサン®」共同販売終了のお知らせ

全薬工業株式会社 （本社：東京都文京区、代表取締役社長：橋本 弘一、以下「全薬工業」）および 中外製薬株式会社 （本社：東京都中央区、代表取締役社長 CEO：奥田 修、以下「中外製薬」）は、全薬工業が...

Announcement of Termination of Co-Promotion of Rituxan® in Japan (Anti-CD20 Monoclonal Antibody)

Zenyaku Kogyo Co., Ltd. Chugai Pharmaceutical Co., Ltd. TOKYO, April 9, 2026 -- Zenyaku Kogyo Co., L...

Q1 2026 Business Update

Henry Schein Medical Announces Winner of Its 2026 Rising Star Award

Unlocking the Potential of Biologics with Advanced Drug Product Manufacturing and Development Technologies

What plunged these chimps into civil war? A new study traces the breakdown

Roaming gangs of tumor cells help spread cancer. Can drugs break them up?

Pharmac to fund two new combination treatments, and widen access to another, for people with a type of blood cancer

Update: IR Library "Olympus Business"

Did quantum sensors help find a U.S. pilot shot down in Iran? Experts doubt it

GTCR Completes Acquisition of Zentiva

9 April 2026Departmental updateKazakhstan becomes first country in Central Asia to earn WHO recognition for regulation of medicines and imported vaccines

Kazakhstan has achieved a major public health milestone, becoming the first country in Central Asia...

Vetter News

When Should I Get LASIK? Age, Eligibility, and Recovery Explained

Is there a best age or time for LASIK? UR Medicine eye doctors explain eligibility, recovery, and ho...

Orion’s production processes in Turku, Finland to become carbon free with new steam plant4/9/2026 Sustainability

Orion has commissioned a new steam plant at its Turku factory, as a result of which the site's pharm...

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

Strengthens three community health models spanning community ‑ embedded care, earlier intervention a...

CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

When Every Minute Matters: Introducing GenomeDx™ ultraRapid Duo and Trio

Announcement of Termination of Co-Promotion of Rituxan ® in Japan (Anti-CD20 Monoclonal Antibody)

Survey finds parents feel pressure over kids’ health | Abbott Newsroom

Immunic to Participate in Scientific and Medical Conferences in April

Stay informed with Immunic’s latest press releases covering corporate updates, preclinical and clini...

WHO releases US$800,000 from its Contingency Fund for Emergencies for Iran health response

10 April 2026, Cairo, Egypt – The World Health Organization (WHO) has released US$800,000 from its C...

Foundayo™ (orforglipron), la nueva pastilla GLP-1 de Lilly que se administra por vía oral para la pérdida de peso, ahora está disponible en Estados Unidos.

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Rick Byrd to Retire from BD

From Signal to Strategy: Using current, credible data for publication impact monitoring and continuous improvement planning

From Signal to Strategy: Using current, credible data for publication impact monitoring and continuous improvement planning

PPC Landing Page Template VHH Services V.2

University College of London Hospitals NHS Trust (UCLH)

Cambridge University Hospitals NHS Foundation Trust

Manchester University NHS Foundation Trust

Hôpital La Pitié Salpêtrière

University of Oklahoma

ISPOR 2026

Clinical investigations for medical devices

How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.

Delpharm to attend CDMO Live Europe 2026

Guidance: Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway

By streamlining decision-making, the MHRA–NICE aligned pathway will help patients access new medicin...

National assessment procedure for medicines

Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Viz.ai Earns Back-to-Back No. 1 Ranking in Black Book Survey of AI Clinical Decision Support Solutions

Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs

Interest is growing around strategies that target the body’s internal energy system itself. Instead...

Delpharm na targach CDMO Live Europe 2026

Delpharm presente al CDMO Live Europe 2026

Delpharm présent au CDMO Live Europe 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Med...

Simplificación de los mecanismos de inscripción para productos importados cosméticos, domisanitarios e higiénicos

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy

Canon launches Ultimion, Japan’s first domestically produced Photon-Counting CT

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

Targeted therapy in early-stage classical Hodgkin lymphoma

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de un lote del cosmético Agrado crema solar SPF 50

Jakość jako podstawowe zobowiązanie

Onbeschikbaarheid van Fibclot 1,5 g poeder en oplosmiddel voor injectie/infusie: aanbevelingen voor artsen-specialisten en ziekenhuisapothekers

Het geneesmiddel Fibclot 1,5 g is tijdelijk onbeschikbaarheid van 9 oktober 2025 tot 31 januari 2027...

Farmak Ranked Among Ukraine’s Top 10 Employers

A simple model makes it possible to predict which patients experiencing a first psychotic episode will recover during the first year

A multicentre team, led by Sergi Mas, lecturer in the Pharmacology Unit of the Department of Clinica...

抗CD20モノクローナル抗体「リツキサン®」共同販売終了のお知らせ

全薬工業株式会社 （本社：東京都文京区、代表取締役社長：橋本 弘一、以下「全薬工業」）および 中外製薬株式会社 （本社：東京都中央区、代表取締役社長 CEO：奥田 修、以下「中外製薬」）は、全薬工業が...

Announcement of Termination of Co-Promotion of Rituxan® in Japan (Anti-CD20 Monoclonal Antibody)

Zenyaku Kogyo Co., Ltd. Chugai Pharmaceutical Co., Ltd. TOKYO, April 9, 2026 -- Zenyaku Kogyo Co., L...